SUNG L HSIA
Medical Practice in Miami, FL
License number
Florida 22428
Issued Date
Dec 22, 1983
Effective Date
Sep 19, 2002
Expiration Date
Jun 30, 2000
Category
Health Care
Type
Clinical Laboratory Personnel
Address
Address
PO Box 16960, Miami, FL 33101
Professional information
Topical Co-Enzyme Q10 Formulations And Methods Of Use
US Patent:
8293227, Oct 23, 2012
Filed:
Mar 1, 2012
Appl. No.:
13/410085
Inventors:
Sung Lan Hsia - Miami FL, US
Niven Rajin Narain - Cambridge MA, US
Jie Li - Miami FL, US
Kathryn J. Russell - Sarasota FL, US
Indushekhar Persaud - Homestead FL, US
Niven Rajin Narain - Cambridge MA, US
Jie Li - Miami FL, US
Kathryn J. Russell - Sarasota FL, US
Indushekhar Persaud - Homestead FL, US
Assignee:
University of Miami - Miami FL
International Classification:
A61K 38/43
US Classification:
424 941
Abstract:
Topical formulations of CoQ10 reduce the rate of tumor growth in an animal subject. In the experiments described herein, CoQ10 was shown to increase the rate of apoptosis in a culture of skin cancer cells but not normal cells. Moreover, treatment of tumor-bearing animals with a topical formulation of CoQ10 was shown to dramatically reduce the rate of tumor growth in the animals.
Co-Enzyme Q10 Formulations And Methods Of Use
US Patent:
8562976, Oct 22, 2013
Filed:
Feb 3, 2012
Appl. No.:
13/366224
Inventors:
Sung Lan Hsia - Miami FL, US
Niven Rajin Narain - Cambridge MA, US
Jie Li - Miami FL, US
Kathryn J. Russell - Sarasota FL, US
Indushekhar Persaud - Homestead FL, US
Niven Rajin Narain - Cambridge MA, US
Jie Li - Miami FL, US
Kathryn J. Russell - Sarasota FL, US
Indushekhar Persaud - Homestead FL, US
Assignee:
University of Miami - Miami FL
International Classification:
A61K 38/43
US Classification:
424 941
Abstract:
Topical formulations of CoQ10 reduce the rate of tumor growth in an animal subject. In the experiments described herein, CoQ10 was shown to increase the rate of apoptosis in a culture of skin cancer cells but not normal cells. Moreover, treatment of tumor-bearing animals with a topical formulation of CoQ10 was shown to dramatically reduce the rate of tumor growth in the animals.
Topical Co-Enzyme Q10 Formulations And Treatment Of Pain, Fatigue And Wounds
US Patent:
2010006, Mar 11, 2010
Filed:
May 2, 2007
Appl. No.:
12/299354
Inventors:
Sung Lan Hsia - Miami FL, US
Niven Rajin Narain - Miami FL, US
Indushekhar Persaud - Homestead FL, US
Niven Rajin Narain - Miami FL, US
Indushekhar Persaud - Homestead FL, US
Assignee:
UNIVERSITY OF MIAMI - Miami FL
International Classification:
A61K 9/127, A61K 38/43, A61K 31/122, C12N 5/00, A61P 29/00, A61P 17/02
US Classification:
424450, 424 941, 514689, 435375
Abstract:
CoQ1O has a stimulatory effect on fibroblasts and keratinocytes, increases ATP production, decreases pain. The formulations are useful for promoting acute wound healing, fatigue and treatment of acute and chronic pain.
Treatment Of Skin Over Androgenicity Using Compositions Containing Pregnenolone
US Patent:
4593021, Jun 3, 1986
Filed:
Aug 16, 1984
Appl. No.:
6/641201
Inventors:
Sung L. Hsia - Miami FL
Walter Voigt - Miami FL
Marty Sawaya - Miami FL
Kathryn Zeoli - Miami FL
Walter Voigt - Miami FL
Marty Sawaya - Miami FL
Kathryn Zeoli - Miami FL
Assignee:
University of Miami - Coral Gables FL
International Classification:
A61K 3156
US Classification:
514182
Abstract:
Disorders of the skin resulting from over androgenicity, such as acne vulgaris, may be treated by applying, to affected areas of the skin, a composition containing a therapeutically effective amount of pregnenolone.
Method For Determining Serum Cholesterol Binding Reserve And Use In Diagnosis
US Patent:
3954409, May 4, 1976
Filed:
Apr 22, 1974
Appl. No.:
5/462818
Inventors:
Sung Lan Hsia - Miami FL
International Classification:
G01N 3300
US Classification:
23230B
Abstract:
The ability of serum to bind cholesterol in soluble lipoprotein complexes is believed to retard the deposition of cholesterol in atherosclerotic plaques. This ability is measured by "serum cholesterol binding reserve" (SCBR), defined as the amount of exogenous cholesterol which a serum specimen is capable of solubilizing in addition to its cholesterol content. A method for determining SCBR has been developed. An excess amount of cholesterol is added to a sample of blood serum and incubated. The amount of cholesterol solubilized by the serum is then measured. Test results in case-control studies of premature myocardial infarction have demonstrated the usefulness of SCBR in assessing the risk of coronary heart disease.
Treatment Of Skin Over Androgenicity Using Compositions Containing Pregnenolone
US Patent:
4622317, Nov 11, 1986
Filed:
Oct 7, 1985
Appl. No.:
6/784900
Inventors:
Sung L. Hsia - Miami FL
Walter Voigt - Miami FL
Marty Sawaya - Miami FL
Kathryn Zeoli - Miami FL
Walter Voigt - Miami FL
Marty Sawaya - Miami FL
Kathryn Zeoli - Miami FL
Assignee:
University of Miami - Coral Gables FL
International Classification:
A61K 3156
US Classification:
514178
Abstract:
Disorders of the skin resulting from over androgenicity, such as acne vulgaris, may be treated by applying, to affected areas of the skin, a composition containing a therapeutically effective amount of pregnenolone.
Topical Co-Enzyme Q10 Formulations And Methods Of Use
US Patent:
8147825, Apr 3, 2012
Filed:
Jan 21, 2005
Appl. No.:
10/597378
Inventors:
Sung Lan Hsia - Miami FL, US
Niven Rajin Narain - Miami FL, US
Jie Li - Miami FL, US
Kathryn J. Russell - Sarasota FL, US
Indushekhar Persaud - Homestead FL, US
Niven Rajin Narain - Miami FL, US
Jie Li - Miami FL, US
Kathryn J. Russell - Sarasota FL, US
Indushekhar Persaud - Homestead FL, US
Assignee:
University of Miami - Miami FL
International Classification:
A61K 38/43
US Classification:
424 941
Abstract:
Topical formulations of CoQ10 reduce the rate of tumor growth in an animal subject. In the experiments described herein, CoQ10 was shown to increase the rate of apoptosis in a culture of skin cancer cells but not normal cells. Moreover, treatment of tumor-bearing animals with a topical formulation of CoQ10 was shown to dramatically reduce the rate of tumor growth in the animals.
Treatment For Hypercholesterolemia
US Patent:
5498607, Mar 12, 1996
Filed:
Apr 23, 1993
Appl. No.:
8/051684
Inventors:
Sung L. Hsia - Miami FL
Jin L. He - Miami FL
Jin L. He - Miami FL
Assignee:
University of Miami - Miami FL
International Classification:
A61K 31685
US Classification:
514 77
Abstract:
The present invention relates to a method of modifying serum cholesterol levels in a mammal by topically administering to the skin of the mammal an effective amount of at least one phospholipid. Atherosclerosis, and related complications, can be treated, or prevented, using the present method.
Method For Treating Living Skin Exhibiting Excessive Sebum Secretion
US Patent:
4172149, Oct 23, 1979
Filed:
Jan 30, 1978
Appl. No.:
5/873320
Inventors:
Jeffrey S. Pinto - East Aurora NY
Sung L. Hsia - Miami FL
Paul L. Warner - Clarence NY
Sung L. Hsia - Miami FL
Paul L. Warner - Clarence NY
Assignee:
Westwood Pharmaceuticals, Inc. - Buffalo NY
International Classification:
A61K 3123
US Classification:
424312
Abstract:
Treats living skin in which sebum secretion is excessive with certain triglycerides to reduce the level of sebum secretion.
Treatment For Hypercholesterolemia
US Patent:
5231090, Jul 27, 1993
Filed:
Jul 30, 1990
Appl. No.:
7/559932
Inventors:
Sung L. Hsia - Miami FL
Jin L. He - Miami FL
Jin L. He - Miami FL
Assignee:
University of Miami - Miami FL
International Classification:
A61K 3166, A61K 31685, A61K 970
US Classification:
514 78
Abstract:
The present invention relates to a method of modifying serum cholesterol levels in a mammal by topically administering to the skin of the mammal an effective amount of at least one phospholipid. Atherosclerosis, and related complications, can be treated, or prevented, using the present method.